Susquehanna International Group, LLP Akero Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 21,501 shares of AKRO stock, worth $688,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,501

Previous 35,437 39.33%

Holding current value

$688,247

Previous $831,000 25.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.45 - $29.34 $298,927 - $408,882	-13,936 Reduced 39.33%	21,501 $616,000
Q2 2024 Aug 15, 2024	SELL	$18.31 - $24.62 $1.26 Million - $1.69 Million	-68,683 Reduced 65.97%	35,437 $831,000
Q1 2024 May 07, 2024	BUY	$17.76 - $31.18 $1.46 Million - $2.57 Million	82,403 Added 379.44%	104,120 $2.63 Million
Q4 2023 Feb 14, 2024	SELL	$11.38 - $50.33 $3.75 Million - $16.6 Million	-329,192 Reduced 93.81%	21,717 $507,000
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $10.6 Million - $13.4 Million	256,446 Added 271.48%	350,909 $17.7 Million
Q2 2023 Aug 11, 2023	SELL	$36.89 - $56.88 $156,413 - $241,171	-4,240 Reduced 4.3%	94,463 $4.41 Million
Q1 2023 May 16, 2023	BUY	$37.27 - $50.24 $2.35 Million - $3.17 Million	63,149 Added 177.61%	98,703 $3.78 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $1.25 Million - $2.05 Million	-37,423 Reduced 51.28%	35,554 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $740,716 - $2.48 Million	72,977 New	72,977 $2.48 Million
Q1 2022 May 16, 2022	SELL	$12.97 - $22.26 $374,067 - $642,000	-28,841 Reduced 51.14%	27,553 $391,000
Q4 2021 Feb 14, 2022	BUY	$19.87 - $26.24 $112,225 - $148,203	5,648 Added 11.13%	56,394 $1.19 Million
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $459,051 - $626,672	-24,614 Reduced 32.66%	50,746 $1.13 Million
Q2 2021 Aug 11, 2021	SELL	$24.81 - $32.35 $3.67 Million - $4.78 Million	-147,765 Reduced 66.23%	75,360 $1.87 Million
Q1 2021 May 17, 2021	BUY	$24.04 - $34.19 $5.02 Million - $7.14 Million	208,854 Added 1463.49%	223,125 $6.47 Million
Q4 2020 Feb 16, 2021	SELL	$25.12 - $29.89 $221,633 - $263,719	-8,823 Reduced 38.2%	14,271 $368,000
Q3 2020 Nov 16, 2020	SELL	$30.79 - $39.92 $156,813 - $203,312	-5,093 Reduced 18.07%	23,094 $711,000
Q2 2020 Aug 14, 2020	SELL	$19.25 - $26.76 $32,859 - $45,679	-1,707 Reduced 5.71%	28,187 $702,000
Q1 2020 May 15, 2020	BUY	$12.8 - $27.05 $382,643 - $808,632	29,894 New	29,894 $634,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.49B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Akero Therapeutics, Inc. Transaction History